We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SERA market cap is 207.36M. The company's latest EPS is USD -1.0731 and P/E is -5.74.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 123k | 42k | 41k | 0 | 24k |
| Operating Income | -11.46M | -8.18M | -8.85M | -9.1M | -9.25M |
| Net Income | -10.54M | -7.21M | -7.93M | -8.1M | -8.3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36k | 25k | 82k | 268k | 306k |
| Operating Income | -16.58M | -17.97M | -35.4M | -45.65M | -39.82M |
| Net Income | -16.52M | -19.85M | -35.01M | -44.19M | -36.24M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 96.68M | 90.06M | 95.44M | 89.89M | 84.86M |
| Total Liabilities | 15.54M | 14.65M | 25.28M | 25.14M | 25.11M |
| Total Equity | 81.14M | 75.41M | 70.16M | 64.75M | 59.75M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.26M | 14.8M | 147.03M | 116.33M | 95.44M |
| Total Liabilities | 12.53M | 12.33M | 8.47M | 17.39M | 25.28M |
| Total Equity | -106.62M | -125.57M | 138.56M | 98.94M | 70.16M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.83M | -20.42M | -27.19M | 4.99M | -934k |
| Investing | 15.23M | 64k | 438k | -5.69M | -540k |
| Financing | 8k | 136k | 752k | 1.05M | 2.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.32M | -16.87M | -31.64M | -34.61M | -27.19M |
| Investing | -6k | -149k | -82.56M | 5.55M | 438k |
| Financing | 33.05M | 9.16M | 159.59M | 5k | 752k |
| Market Cap | 207.36M |
| Price to Earnings Ratio | -5.74 |
| Price to Sales Ratio | 676.92 |
| Price to Cash Ratio | 53.61 |
| Price to Book Ratio | 2.97 |
| Dividend Yield | - |
| Shares Outstanding | 33.77M |
| Average Volume (1 week) | 122.51k |
| Average Volume (1 Month) | 80.48k |
| 52 Week Change | 265.48% |
| 52 Week High | 12.355 |
| 52 Week Low | 1.67 |
| Spread (Intraday) | 1.05 (15.15%) |
| Company Name | Sera Prognostics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.seraprognostics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
